BMTBiomaterials TranslationalTBA2096-112XBiomaterials Translational10.12336/biomatertransl.2022.03.003ReviewAdvances and perspective on animal models and hydrogel biomaterials for diabetic wound healinghttps://artdesignp.com/journal/BMT/3/3/10.12336/biomatertransl.2022.03.003HuYiqiang,XiongYuan,TaoRanyang,XueHang,ChenLang,LinZe,C. PanayiAdriana,MiBobin,LiuGuohui2022332022-09-28Diabetic wounds are a common complication in diabetes patients. Due to peripheral nerve damage and vascular dysfunction, diabetic wounds are prone to progress to local ulcers, wound gangrene and even to require amputation, bringing huge psychological and economic burdens to patients. However, the current treatment methods for diabetic wounds mainly include wound accessories, negative pressure drainage, skin grafting and surgery; there is still no ideal treatment to promote diabetic wound healing at present. Appropriate animal models can simulate the physiological mechanism of diabetic wounds, providing a basis for translational research in treating diabetic wound healing. Although there are no animal models that can fully mimic the pathophysiological mechanisms of diabetic wounds in humans, it is vital to explore animal simulation models used in basic research and preclinical studies of diabetic wounds. In addition, hydrogel materials are regarded as a promising treatment for diabetic wounds because of their good antimicrobial activity, biocompatibility, biodegradation and appropriate mechanical properties. Herein, we review and discuss the different animal models used to investigate the pathological mechanisms of diabetic wounds. We further discuss the promising future application of hydrogel biomaterials in diabetic wound healing.animal models ; diabetic wound ; hydrogel biomaterials ; pathomechanism

1. Gandhi, G. Y.; Mooradian, A. D. Management of hyperglycemia in older adults with type 2 diabetes. Drugs Aging. 2022, 39, 39-58.  2. Graves, L. E.; Donaghue, K. C. Vascular complication in adolescents with diabetes mellitus. Front Endocrinol (Lausanne). 2020, 11, 370.  3. Wan, G.; Chen, Y.; Chen, J.; Yan, C.; Wang, C.; Li, W.; Mao, R.; Machens, H. G.; Yang, X.; Chen, Z. Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing. J Mol Med (Berl). 2022, 100, 485-498.  4. den Dekker, A.; Davis, F. M.; Kunkel, S. L.; Gallagher, K. A. Targeting epigenetic mechanisms in diabetic wound healing. Transl Res. 2019, 204, 39-50.  5. Vijayakumar, V.; Samal, S. K.; Mohanty, S.; Nayak, S. K. Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management. Int J Biol Macromol. 2019, 122, 137-148.  6. Phang, S. J.; Arumugam, B.; Kuppusamy, U. R.; Fauzi, M. B.; Looi, M. L. A review of diabetic wound models-Novel insights into diabetic foot ulcer. J Tissue Eng Regen Med. 2021, 15, 1051-1068.  7. Nowak, N. C.; Menichella, D. M.; Miller, R.; Paller, A. S. Cutaneous innervation in impaired diabetic wound healing. Transl Res. 2021, 236, 87-108.  8. Greenhalgh, D. G. Wound healing and diabetes mellitus. Clin Plast Surg. 2003, 30, 37-45.  9. Wang, C.; Guo, M.; Zhang, N.; Wang, G. Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis. Complement Ther Clin Pract. 2019, 34, 123-131.  10. Khamaisi, M.; Balanson, S. Dysregulation of wound healing mechanisms in diabetes and the importance of negative pressure wound therapy (NPWT). Diabetes Metab Res Rev. 2017, 33, e2929.  11. Gurtner, G. C.; Werner, S.; Barrandon, Y.; Longaker, M. T. Wound repair and regeneration. Nature. 2008, 453, 314-321.  12. Nourian Dehkordi, A.; Mirahmadi Babaheydari, F.; Chehelgerdi, M.; Raeisi Dehkordi, S. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 2019, 10, 111.  13. Dekoninck, S.; Blanpain, C. Stem cell dynamics, migration and plasticity during wound healing. Nat Cell Biol. 2019, 21, 18-24.  14. Yang, F.; Bai, X.; Dai, X.; Li, Y. The biological processes during wound healing. Regen Med. 2021, 16, 373-390.  15. Moura, L. I.; Dias, A. M.; Carvalho, E.; de Sousa, H. C. Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review. Acta Biomater. 2013, 9, 7093-7114.  16. Broughton, G., 2nd; Janis, J. E.; Attinger, C. E. Wound healing: an overview. Plast Reconstr Surg. 2006, 117, 1e-S-32e-S.  17. Yang, R.; Liu, F.; Wang, J.; Chen, X.; Xie, J.; Xiong, K. Epidermal stem cells in wound healing and their clinical applications. Stem Cell Res Ther. 2019, 10, 229.  18. Han, G.; Ceilley, R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017, 34, 599-610.  19. Rani, S.; Ritter, T. The exosome - a naturally secreted nanoparticle and its application to wound healing. Adv Mater. 2016, 28, 5542-5552.  20. Rai, V.; Moellmer, R.; Agrawal, D. K. Clinically relevant experimental rodent models of diabetic foot ulcer. Mol Cell Biochem. 2022, 477, 1239-1247.  21. Goyal, S. N.; Reddy, N. M.; Patil, K. R.; Nakhate, K. T.; Ojha, S.; Patil, C. R.; Agrawal, Y. O. Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact. 2016, 244, 49-63.  22. Ansell, D. M.; Marsh, C.; Walker, L.; Hardman, M. J.; Holden, K. Evaluating STZ-induced impaired wound healing in rats. J Invest Dermatol. 2018, 138, 994-997.  23. Yu, M.; Liu, W.; Li, J.; Lu, J.; Lu, H.; Jia, W.; Liu, F. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020, 11, 350.  24. Szkudelski, T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med (Maywood). 2012, 237, 481-490.  25. Ahmed, R.; Afreen, A.; Tariq, M.; Zahid, A. A.; Masoud, M. S.; Ahmed, M.; Ali, I.; Akram, Z.; Hasan, A. Bone marrow mesenchymal stem cells preconditioned with nitric-oxide-releasing chitosan/PVA hydrogel accelerate diabetic wound healing in rabbits. Biomed Mater. 2021, 16, 035014.  26. Malone-Povolny, M. J.; Maloney, S. E.; Schoenfisch, M. H. Nitric oxide therapy for diabetic wound healing. Adv Healthc Mater. 2019, 8, e1801210.  27. Hoppenbrouwers, T.; Tuk, B.; Fijneman, E. M.; de Maat, M. P.; van Neck, J. W. Fibrin improves skin wound perfusion in a diabetic rat model. Thromb Res. 2017, 151, 36-40.  28. Kaymakcalan, O. E.; Abadeer, A.; Goldufsky, J. W.; Galili, U.; Karinja, S. J.; Dong, X.; Jin, J. L.; Samadi, A.; Spector, J. A. Topical α-gal nanoparticles accelerate diabetic wound healing. Exp Dermatol. 2020, 29, 404-413.  29. Dunn, L.; Prosser, H. C.; Tan, J. T.; Vanags, L. Z.; Ng, M. K.; Bursill, C. A. Murine model of wound healing. J Vis Exp. 2013, e50265.  30. Li, G.; Ko, C. N.; Li, D.; Yang, C.; Wang, W.; Yang, G. J.; Di Primo, C.; Wong, V. K. W.; Xiang, Y.; Lin, L.; Ma, D. L.; Leung, C. H. A small molecule HIF-1α stabilizer that accelerates diabetic wound healing. Nat Commun. 2021, 12, 3363.  31. King, A. J. The use of animal models in diabetes research. Br J Pharmacol. 2012, 166, 877-894.  32. Yang, J.; Chen, Z.; Pan, D.; Li, H.; Shen, J. Umbilical cord-derived mesenchymal stem cell-derived exosomes combined pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomedicine. 2020, 15, 5911-5926.  33. Zhang, J.; Zhou, R.; Xiang, C.; Jia, Q.; Wu, H.; Yang, H. Huangbai Liniment accelerated wound healing by activating Nrf2 signaling in diabetes. Oxid Med Cell Longev. 2020, 2020, 4951820.  34. Liu, W.; Yu, M.; Xie, D.; Wang, L.; Ye, C.; Zhu, Q.; Liu, F.; Yang, L. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020, 11, 259.  35. Abo El-Magd, N. F.; Ramadan, N. M.; Eraky, S. M. The ameliorative effect of bromelain on STZ-induced type 1 diabetes in rats through Oxi-LDL/LPA/LPAR1 pathway. Life Sci. 2021, 285, 119982.  36. Jayasimhan, A.; Mansour, K. P.; Slattery, R. M. Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse. Clin Sci (Lond). 2014, 126, 1-18.  37. Driver, J. P.; Serreze, D. V.; Chen, Y. G. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol. 2011, 33, 67-87.  38. Giarratana, N.; Penna, G.; Adorini, L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol. 2007, 380, 285-311.  39. Irvin, A. E.; Jhala, G.; Zhao, Y.; Blackwell, T. S.; Krishnamurthy, B.; Thomas, H. E.; Kay, T. W. H. NF-κB is weakly activated in the NOD mouse model of type 1 diabetes. Sci Rep. 2018, 8, 4217.  40. Jiang, Y.; Xie, F.; Lv, X.; Wang, S.; Liao, X.; Yu, Y.; Dai, Q.; Zhang, Y.; Meng, J.; Hu, G.; Peng, Z.; Tao, L. Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice. FASEB J. 2021, 35, e21198.  41. Wang, M.; Song, L.; Strange, C.; Dong, X.; Wang, H. Therapeutic effects of adipose stem cells from diabetic mice for the treatment of type 2 diabetes. Mol Ther. 2018, 26, 1921-1930.  42. Sakai, S.; Yamamoto, T.; Takabatake, Y.; Takahashi, A.; Namba-Hamano, T.; Minami, S.; Fujimura, R.; Yonishi, H.; Matsuda, J.; Hesaka, A.; Matsui, I.; Matsusaka, T.; Niimura, F.; Yanagita, M.; Isaka, Y. Proximal tubule autophagy differs in type 1 and 2 diabetes. J Am Soc Nephrol. 2019, 30, 929-945.  43. Heydemann, A. An overview of murine high fat diet as a model for type 2 diabetes mellitus. J Diabetes Res. 2016, 2016, 2902351.  44. Silamiķele, L.; Silamiķelis, I.; Ustinova, M.; Kalniņa, Z.; Elbere, I.; Petrovska, R.; Kalniņa, I.; Kloviņš, J. Metformin strongly affects gut microbiome composition in high-fat diet-induced type 2 diabetes mouse model of both sexes. Front Endocrinol (Lausanne). 2021, 12, 626359.  45. Grada, A.; Mervis, J.; Falanga, V. Research techniques made simple: animal models of wound healing. J Invest Dermatol. 2018, 138, 2095-2105.  46. Saleem Mir, M.; Maqbool Darzi, M.; Khalil Baba, O.; Khan, H. M.; Kamil, S. A.; Sofi, A. H.; Wani, S. A. Streptozotocin induced acute clinical effects in rabbits (Oryctolagus cuniculus). Iran J Pathol. 2015, 10, 206-213.  47. Conaway, H. H.; Faas, F. H.; Smith, S. D.; Sanders, L. L. Spontaneous diabetes mellitus in the New Zealand white rabbit: physiologic characteristics. Metabolism. 1981, 30, 50-56.  48. Zhang, J.; Hu, W.; Diao, Q.; Wang, Z.; Miao, J.; Chen, X.; Xue, Z. Therapeutic effect of the epidermal growth factor on diabetic foot ulcer and the underlying mechanisms. Exp Ther Med. 2019, 17, 1643-1648.  49. O’Loughlin, A.; Kulkarni, M.; Vaughan, E. E.; Creane, M.; Liew, A.; Dockery, P.; Pandit, A.; O’Brien, T. Autologous circulating angiogenic cells treated with osteopontin and delivered via a collagen scaffold enhance wound healing in the alloxan-induced diabetic rabbit ear ulcer model. Stem Cell Res Ther. 2013, 4, 158.  50. O’Loughlin, A.; Kulkarni, M.; Creane, M.; Vaughan, E. E.; Mooney, E.; Shaw, G.; Murphy, M.; Dockery, P.; Pandit, A.; O’Brien, T. Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer. Diabetes. 2013, 62, 2588-2594.  51. Velander, P.; Theopold, C.; Hirsch, T.; Bleiziffer, O.; Zuhaili, B.; Fossum, M.; Hoeller, D.; Gheerardyn, R.; Chen, M.; Visovatti, S.; Svensson, H.; Yao, F.; Eriksson, E. Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia. Wound Repair Regen. 2008, 16, 288-293.  52. Ramirez, H. A.; Pastar, I.; Jozic, I.; Stojadinovic, O.; Stone, R. C.; Ojeh, N.; Gil, J.; Davis, S. C.; Kirsner, R. S.; Tomic-Canic, M. Staphylococcus aureus triggers induction of miR-15B-5P to diminish DNA repair and deregulate inflammatory response in diabetic foot ulcers. J Invest Dermatol. 2018, 138, 1187-1196.  53. Sawaya, A. P.; Jozic, I.; Stone, R. C.; Pastar, I.; Egger, A. N.; Stojadinovic, O.; Glinos, G. D.; Kirsner, R. S.; Tomic-Canic, M. Mevastatin promotes healing by targeting caveolin-1 to restore EGFR signaling. JCI Insight. 2019, 4, e129320.  54. Podell, B. K.; Ackart, D. F.; Richardson, M. A.; DiLisio, J. E.; Pulford, B.; Basaraba, R. J. A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment. Dis Model Mech. 2017, 10, 151-162.  55. Verhagen, J.; Smith, E. L.; Whettlock, E. M.; Macintyre, B.; Peakman, M. Proinsulin-mediated induction of type 1 diabetes in HLA-DR4-transgenic mice. Sci Rep. 2018, 8, 14106.  56. Perez-Favila, A.; Martinez-Fierro, M. L.; Rodriguez-Lazalde, J. G.; Cid-Baez, M. A.; Zamudio-Osuna, M. J.; Martinez-Blanco, M. D. R.; Mollinedo-Montaño, F. E.; Rodriguez-Sanchez, I. P.; Castañeda-Miranda, R.; Garza-Veloz, I. Current therapeutic strategies in diabetic foot ulcers. Medicina (Kaunas). 2019, 55, 714.  57. Dixon, D.; Edmonds, M. Managing diabetic foot ulcers: pharmacotherapy for wound healing. Drugs. 2021, 81, 29-56.  58. Reardon, R.; Simring, D.; Kim, B.; Mortensen, J.; Williams, D.; Leslie, A. The diabetic foot ulcer. Aust J Gen Pract. 2020, 49, 250-255.  59. Lim, J. Z.; Ng, N. S.; Thomas, C. Prevention and treatment of diabetic foot ulcers. J R Soc Med. 2017, 110, 104-109.  60. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020, 43, S135-S151.  61. Migdalis, I.; Czupryniak, L.; Lalic, N.; Leslie, R. D.; Papanas, N.; Valensi, P. Diabetic microvascular complications. Int J Endocrinol. 2018, 2018, 5683287.  62. Strain, W. D.; Paldánius, P. M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018, 17, 57.  63. Forbes, J. M.; Cooper, M. E. Mechanisms of diabetic complications. Physiol Rev. 2013, 93, 137-188.  64. Alicic, R. Z.; Rooney, M. T.; Tuttle, K. R. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017, 12, 2032-2045.  65. Ricciardi, C. A.; Gnudi, L. Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies. Metabolism. 2021, 124, 154890.  66. Schoina, M.; Loutradis, C.; Theodorakopoulou, M.; Dimitroulas, T.; Triantafillidou, E.; Doumas, M.; Karagiannis, A.; Garyfallos, A.; Papagianni, A.; Sarafidis, P. The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease. Microcirculation. 2021, 28, e12665.  67. Sabanayagam, C.; Banu, R.; Chee, M. L.; Lee, R.; Wang, Y. X.; Tan, G.; Jonas, J. B.; Lamoureux, E. L.; Cheng, C. Y.; Klein, B. E. K.; Mitchell, P.; Klein, R.; Cheung, C. M. G.; Wong, T. Y. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol. 2019, 7, 140-149.  68. Wu, L.; Gunton, J. E. The Changing landscape of pharmacotherapy for diabetes mellitus: a review of cardiovascular outcomes. Int J Mol Sci. 2019, 20, 5853.  69. Low Wang, C. C.; Everett, B. M.; Burman, K. D.; Wilson, P. W. F. Cardiovascular safety trials for all new diabetes mellitus drugs? Circulation. 2019, 139, 1741-1743.  70. Apelqvist, J. A.; Lepäntalo, M. J. The ulcerated leg: when to revascularize. Diabetes Metab Res Rev. 2012, 28 Suppl 1, 30-35.  71. Korzon-Burakowska, A.; Edmonds, M. Role of the microcirculation in diabetic foot ulceration. Int J Low Extrem Wounds. 2006, 5, 144-148.  72. Grennan, D. Diabetic foot ulcers. JAMA. 2019, 321, 114.  73. Chao, C. Y.; Cheing, G. L. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev. 2009, 25, 604-614.  74. Volmer-Thole, M.; Lobmann, R. Neuropathy and diabetic foot syndrome. Int J Mol Sci. 2016, 17, 917.  75. Hicks, C. W.; Selvin, E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019, 19, 86.  76. Balasubramanian, G.; Vas, P.; Chockalingam, N.; Naemi, R. A synoptic overview of neurovascular interactions in the foot. Front Endocrinol (Lausanne). 2020, 11, 308.  77. Lechleitner, M.; Abrahamian, H.; Francesconi, C.; Kofler, M.; Sturm, W.; Köhler, G. Diabetic neuropathy and diabetic foot syndrome (Update 2019). Wien Klin Wochenschr. 2019, 131, 141-150.  78. Lima, A. L.; Illing, T.; Schliemann, S.; Elsner, P. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017, 18, 541-553.  79. Zilliox, L. A. Diabetes and peripheral nerve disease. Clin Geriatr Med. 2021, 37, 253-267.  80. Zhang, Y.; Lazzarini, P. A.; McPhail, S. M.; van Netten, J. J.; Armstrong, D. G.; Pacella, R. E. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020, 43, 964-974.  81. Yang, H.; Sloan, G.; Ye, Y.; Wang, S.; Duan, B.; Tesfaye, S.; Gao, L. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol (Lausanne). 2019, 10, 929.  82. Tuttolomondo, A.; Maida, C.; Pinto, A. Diabetic foot syndrome: immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop. 2015, 6, 62-76.  83. Giri, B.; Dey, S.; Das, T.; Sarkar, M.; Banerjee, J.; Dash, S. K. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed Pharmacother. 2018, 107, 306-328.  84. Davis, F. M.; Kimball, A.; Boniakowski, A.; Gallagher, K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep. 2018, 18, 2.  85. Gardner, S. E.; Frantz, R. A. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008, 10, 44-53.  86. Adeghate, J.; Nurulain, S.; Tekes, K.; Fehér, E.; Kalász, H.; Adeghate, E. Novel biological therapies for the treatment of diabetic foot ulcers. Expert Opin Biol Ther. 2017, 17, 979-987.  87. Pitocco, D.; Spanu, T.; Di Leo, M.; Vitiello, R.; Rizzi, A.; Tartaglione, L.; Fiori, B.; Caputo, S.; Tinelli, G.; Zaccardi, F.; Flex, A.; Galli, M.; Pontecorvi, A.; Sanguinetti, M. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci. 2019, 23, 26-37.  88. Ghotaslou, R.; Memar, M. Y.; Alizadeh, N. Classification, microbiology and treatment of diabetic foot infections. J Wound Care. 2018, 27, 434-441.  89. Dumville, J. C.; Lipsky, B. A.; Hoey, C.; Cruciani, M.; Fiscon, M.; Xia, J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017, 6, CD011038.  90. Everett, E.; Mathioudakis, N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018, 1411, 153-165.  91. Alavi, A.; Sibbald, R. G.; Mayer, D.; Goodman, L.; Botros, M.; Armstrong, D. G.; Woo, K.; Boeni, T.; Ayello, E. A.; Kirsner, R. S. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014, 70, 1.e1-18; quiz 19-20.  92. Aldana, P. C.; Khachemoune, A. Diabetic foot ulcers: appraising standard of care and reviewing new trends in management. Am J Clin Dermatol. 2020, 21, 255-264.  93. Lebrun, E.; Tomic-Canic, M.; Kirsner, R. S. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen. 2010, 18, 433-438.  94. Edwards, J.; Stapley, S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010, 2010, CD003556.  95. Alexiadou, K.; Doupis, J. Management of diabetic foot ulcers. Diabetes Ther. 2012, 3, 4.  96. Patry, J.; Blanchette, V. Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis. Int Wound J. 2017, 14, 1055-1065.  97. Singh, N.; Armstrong, D. G.; Lipsky, B. A. Preventing foot ulcers in patients with diabetes. JAMA. 2005, 293, 217-228.  98. Sen, P.; Demirdal, T.; Emir, B. Meta-analysis of risk factors for amputation in diabetic foot infections. Diabetes Metab Res Rev. 2019, 35, e3165.  99. Macdonald, K. E.; Boeckh, S.; Stacey, H. J.; Jones, J. D. The microbiology of diabetic foot infections: a meta-analysis. BMC Infect Dis. 2021, 21, 770.  100. Barwell, N. D.; Devers, M. C.; Kennon, B.; Hopkinson, H. E.; McDougall, C.; Young, M. J.; Robertson, H. M. A.; Stang, D.; Dancer, S. J.; Seaton, A.; Leese, G. P.; Scottish Diabetes Foot Action Group. Diabetic foot infection: Antibiotic therapy and good practice recommendations. Int J Clin Pract. 2017, 71, e13006.  101. Lipsky, B. A.; Berendt, A. R.; Cornia, P. B.; Pile, J. C.; Peters, E. J.; Armstrong, D. G.; Deery, H. G.; Embil, J. M.; Joseph, W. S.; Karchmer, A. W.; Pinzur, M. S.; Senneville, E.; Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012, 54, e132-173.  102. Lipsky, B. A.; Berendt, A. R.; Cornia, P. B.; Pile, J. C.; Peters, E. J.; Armstrong, D. G.; Deery, H. G.; Embil, J. M.; Joseph, W. S.; Karchmer, A. W.; Pinzur, M. S.; Senneville, E.; Infectious Diseases Society of America. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012, 54, 1679-1684.  103. Cavanagh, P. R.; Ulbrecht, J. S.; Caputo, G. M. New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev. 2000, 16 Suppl 1, S6-S10.  104. Ahluwalia, R.; Maffulli, N.; Lázaro-Martínez, J. L.; Kirketerp-Møller, K.; Reichert, I. Diabetic foot off loading and ulcer remission: Exploring surgical off-loading. Surgeon. 2021, 19, e526-e535.  105. Zwaferink, J. B. J.; Custers, W.; Paardekooper, I.; Berendsen, H. A.; Bus, S. A. Optimizing footwear for the diabetic foot: Data-driven custom-made footwear concepts and their effect on pressure relief to prevent diabetic foot ulceration. PLoS One. 2020, 15, e0224010.  106. Bus, S. A. Foot structure and footwear prescription in diabetes mellitus. Diabetes Metab Res Rev. 2008, 24 Suppl 1, S90-95.  107. Peter-Riesch, B. The diabetic foot: The never-ending challenge. Endocr Dev. 2016, 31, 108-134.  108. Mavrogenis, A. F.; Megaloikonomos, P. D.; Antoniadou, T.; Igoumenou, V. G.; Panagopoulos, G. N.; Dimopoulos, L.; Moulakakis, K. G.; Sfyroeras, G. S.; Lazaris, A. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT Open Rev. 2018, 3, 513-525.  109. Caetano, A. P.; Conde Vasco, I.; Veloso Gomes, F.; Costa, N. V.; Luz, J. H.; Spaepen, E.; Formiga, A.; Coimbra, É.; Neves, J.; Bilhim, T. Successful revascularization has a significant impact on limb salvage rate and wound healing for patients with diabetic foot ulcers: single-centre retrospective analysis with a multidisciplinary approach. Cardiovasc Intervent Radiol. 2020, 43, 1449-1459.  110. Hinchliffe, R. J.; Brownrigg, J. R.; Andros, G.; Apelqvist, J.; Boyko, E. J.; Fitridge, R.; Mills, J. L.; Reekers, J.; Shearman, C. P.; Zierler, R. E.; Schaper, N. C.; International Working Group on the Diabetic Foot. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2016, 32 Suppl 1, 136-144.  111. Hicks, C. W.; Canner, J. K.; Sherman, R. L.; Black, J. H., 3rd; Lum, Y. W.; Abularrage, C. J. Evaluation of revascularization benefit quartiles using the Wound, Ischemia, and foot Infection classification system for diabetic patients with chronic limb-threatening ischemia. J Vasc Surg. 2021, 74, 1232-1239.e3.  112. Causey, M. W.; Ahmed, A.; Wu, B.; Gasper, W. J.; Reyzelman, A.; Vartanian, S. M.; Hiramoto, J. S.; Conte, M. S. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016, 63, 1563-1573.e2.  113. Baltzis, D.; Eleftheriadou, I.; Veves, A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther. 2014, 31, 817-836.  114. Vatankhah, N.; Jahangiri, Y.; Landry, G. J.; Moneta, G. L.; Azarbal, A. F. Effect of systemic insulin treatment on diabetic wound healing. Wound Repair Regen. 2017, 25, 288-291.  115. Fan, H. J.; Yu, J. H.; Cui, G. M.; Zhang, W. Y.; Yang, X.; Dong, Q. J. Insulin pump for the treatment of diabetes in combination with ulcerative foot infections. J Biol Regul Homeost Agents. 2016, 30, 465-470.  116. Lima, M. H.; Caricilli, A. M.; de Abreu, L. L.; Araújo, E. P.; Pelegrinelli, F. F.; Thirone, A. C.; Tsukumo, D. M.; Pessoa, A. F.; dos Santos, M. F.; de Moraes, M. A.; Carvalheira, J. B.; Velloso, L. A.; Saad, M. J. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLoS One. 2012, 7, e36974.  117. Sun, Y.; Fan, W.; Yang, W.; Wang, G.; Yu, G.; Zhang, D.; Wang, Y. Effects of intermittent irrigation of insulin solution combined with continuous drainage of vacuum sealing drainage in chronic diabetic lower limb ulcers. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015, 29, 812-817.  118. Saboo, A.; Rathnayake, A.; Vangaveti, V. N.; Malabu, U. H. Wound healing effects of dipeptidyl peptidase-4 inhibitors: An emerging concept in management of diabetic foot ulcer-A review. Diabetes Metab Syndr. 2016, 10, 113-119.  119. Zolali, E.; Rezabakhsh, A.; Nabat, E.; Jaberi, H.; Rahbarghazi, R.; Garjani, A. Metformin effect on endocan biogenesis in human endothelial cells under diabetic condition. Arch Med Res. 2019, 50, 304-314.  120. Seo, E.; Lim, J. S.; Jun, J. B.; Choi, W.; Hong, I. S.; Jun, H. S. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing. J Transl Med. 2017, 15, 35.  121. Zhang, L.; Ma, Y.; Pan, X.; Chen, S.; Zhuang, H.; Wang, S. A composite hydrogel of chitosan/heparin/poly(γ-glutamic acid) loaded with superoxide dismutase for wound healing. Carbohydr Polym. 2018, 180, 168-174.  122. Gong, C.; Wu, Q.; Wang, Y.; Zhang, D.; Luo, F.; Zhao, X.; Wei, Y.; Qian, Z. A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials. 2013, 34, 6377-6387.  123. Ma, H.; Zhou, Q.; Chang, J.; Wu, C. Grape seed-inspired smart hydrogel scaffolds for melanoma therapy and wound healing. ACS Nano. 2019, 13, 4302-4311.  124. Mao, C.; Xiang, Y.; Liu, X.; Cui, Z.; Yang, X.; Yeung, K. W. K.; Pan, H.; Wang, X.; Chu, P. K.; Wu, S. Photo-inspired antibacterial activity and wound healing acceleration by hydrogel embedded with Ag/Ag@AgCl/ZnO nanostructures. ACS Nano. 2017, 11, 9010-9021.  125. Eke, G.; Mangir, N.; Hasirci, N.; MacNeil, S.; Hasirci, V. Development of a UV crosslinked biodegradable hydrogel containing adipose derived stem cells to promote vascularization for skin wounds and tissue engineering. Biomaterials. 2017, 129, 188-198.  126. Han, L.; Lu, X.; Wang, M.; Gan, D.; Deng, W.; Wang, K.; Fang, L.; Liu, K.; Chan, C. W.; Tang, Y.; Weng, L. T.; Yuan, H. A mussel-inspired conductive, self-adhesive, and self-healable tough hydrogel as cell stimulators and implantable bioelectronics. Small. 2017, 13, 1601916.  127. Zhang, K.; Jia, Z.; Yang, B.; Feng, Q.; Xu, X.; Yuan, W.; Li, X.; Chen, X.; Duan, L.; Wang, D.; Bian, L. Adaptable hydrogels mediate cofactor-assisted activation of biomarker-responsive drug delivery via positive feedback for enhanced tissue regeneration. Adv Sci (Weinh). 2018, 5, 1800875.  128. Wang, M.; Wang, C.; Chen, M.; Xi, Y.; Cheng, W.; Mao, C.; Xu, T.; Zhang, X.; Lin, C.; Gao, W.; Guo, Y.; Lei, B. Efficient angiogenesis-based diabetic wound healing/skin reconstruction through bioactive antibacterial adhesive ultraviolet shielding nanodressing with exosome release. ACS Nano. 2019, 13, 10279-10293.  129. Shi, Q.; Luo, X.; Huang, Z.; Midgley, A. C.; Wang, B.; Liu, R.; Zhi, D.; Wei, T.; Zhou, X.; Qiao, M.; Zhang, J.; Kong, D.; Wang, K. Cobalt-mediated multi-functional dressings promote bacteria-infected wound healing. Acta Biomater. 2019, 86, 465-479.  130. Annabi, N.; Rana, D.; Shirzaei Sani, E.; Portillo-Lara, R.; Gifford, J. L.; Fares, M. M.; Mithieux, S. M.; Weiss, A. S. Engineering a sprayable and elastic hydrogel adhesive with antimicrobial properties for wound healing. Biomaterials. 2017, 139, 229-243.  131. Li, L.; Yan, B.; Yang, J.; Chen, L.; Zeng, H. Novel mussel-inspired injectable self-healing hydrogel with anti-biofouling property. Adv Mater. 2015, 27, 1294-1299.  132. Guo, C.; Wu, Y.; Li, W.; Wang, Y.; Kong, Q. Development of a microenvironment-responsive hydrogel promoting chronically infected diabetic wound healing through sequential hemostatic, antibacterial, and angiogenic activities. ACS Appl Mater Interfaces. 2022, 14, 30480-30492.  133. Hao, Y.; Zhao, W.; Zhang, H.; Zheng, W.; Zhou, Q. Carboxymethyl chitosan-based hydrogels containing fibroblast growth factors for triggering diabetic wound healing. Carbohydr Polym. 2022, 287, 119336.  134. Xu, Z.; Liu, Y.; Ma, R.; Chen, J.; Qiu, J.; Du, S.; Li, C.; Wu, Z.; Yang, X.; Chen, Z.; Chen, T. Thermosensitive hydrogel incorporating prussian blue nanoparticles promotes diabetic wound healing via ROS scavenging and mitochondrial function restoration. ACS Appl Mater Interfaces. 2022, 14, 14059-14071.  135. Laiva, A. L.; O’Brien, F. J.; Keogh, M. B. Innovations in gene and growth factor delivery systems for diabetic wound healing. J Tissue Eng Regen Med. 2018, 12, e296-e312.  136. Niu, H.; Li, H.; Guan, Y.; Zhou, X.; Li, Z.; Zhao, S. L.; Chen, P.; Tan, T.; Zhu, H.; Bergdall, V.; Xu, X.; Ma, J.; Guan, J. Sustained delivery of rhMG53 promotes diabetic wound healing and hair follicle development. Bioact Mater. 2022, 18, 104-115.  137. Lee, Y. H.; Lin, S. J. Chitosan/PVA hetero-composite hydrogel containing antimicrobials, perfluorocarbon nanoemulsions, and growth factor-loaded nanoparticles as a multifunctional dressing for diabetic wound healing: synthesis, characterization, and in vitro/in vivo evaluation. Pharmaceutics. 2022, 14, 537.  138. Wu, C.; Long, L.; Zhang, Y.; Xu, Y.; Lu, Y.; Yang, Z.; Guo, Y.; Zhang, J.; Hu, X.; Wang, Y. Injectable conductive and angiogenic hydrogels for chronic diabetic wound treatment. J Control Release. 2022, 344, 249-260.  139. Hu, Y.; Wu, B.; Xiong, Y.; Tao, R.; Panayi, A. C.; Chen, L.; Tian, W.; Xue, H.; Shi, L.; Zhang, X.; Xiong, L.; Mi, B.; Liu, G. Cryogenic 3D printed hydrogel scaffolds loading exosomes accelerate diabetic wound healing. Chem Eng J. 2021, 426, 130634.